THROMBOTIC COMPLICATIONS IN CHILDREN IN THE POSTCOVID PERIOD: CLINICAL CASES
Abstract
COVID-19 is at high risk for complications such as acute myocardial injury, kidney failure, or thromboembolic complications. The consequences and manifestations of the post-covid syndrome are different. To date, the pathogenesis of the disease caused by this virus (COVID-19) remains unclear, while there is more and more data confirming the important role of microcirculation disorders in the development of this disease, which are supposed to be systemic. These can be newly appeared symptoms of the acute stage of coronavirus infection, as well as new ones.
The article presents clinical cases of thrombotic complications in children after suffering COVID- 19, obtained on the basis of the Department of Pediatric Cardiorheumatology of the National Center for Maternal and Child Welfare. The report reflects the options for thrombotic complications after a
new coronavirus infection in children with congenital heart defects, as well as cases of thrombosis of the veins of the extremities and cerebral vessels. infection, as well as early detection of initial signs of such complications.
Keywords:
children, clinical case, thrombosis, blood vessels, COVID-19, postcovid syndrome, congenital heart defects, stroke.References
1. Плешко А.А., Статкевич Т.В., Петрова Е.Б., Митьковская Н.П. Клинический случай внутрисердечного тромбоза на фоне перенесенной инфекции SARS-CoV-2. Неотложная кардиология и кардиоваскулярные риски. 2022;6(1):1539–1546. [Pleshko A.A., Statkevich T.V., Petrova E.B., Mit'kovskaja N.P. A clinical case of intracardiac thrombosis associated with SARS-CoV-2 infection. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski = Emergency cardiology and cardiovascular risks.2022;6(6):1539-1546 (in Russ.).]
2. Министерство здравоохранения Российской Федерации. Методические рекомендации «Особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (COVID-19) у детей». Версия 2 (03.07.2020). 2020. Режим доступа https://www.consultant.ru/document/ cons_doc_LAW_351351/ [Ministry of health of the Russian Federation. Metodicheskie rekomendacii. Osobennosti klinicheskih projavlenij i lechenija zabolevanija, vyzvannogo novoj koronavirusnoj infekciej (COVID-19) u detej. Versija 2. (03.07.2020). 2020. (in Russ.).]
3. Radke RM, Frenzel T, Baumgartner H, Diller GP. Adult congenital heart disease and the COVID-19 pandemic. Heart. 2020;106:1302-1309. https://doi.org/ 10.1136/heartjnl-2020-317258
4. Reyes Gil M, Barouqa M, Szymanski J, Gonzalez-Lugo JD, Rahman S, Billett HH. Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19). JAMA Network Open. 2020;3(8):e2017539. https://doi.org /10.1001/jamanetworkopen.2020.17539
5. Likely increase in the risk of death or disability from stroke during the COVID-19 pandemic. The European Stroke Organisation (ESO) statement. By: Bart van der Worp, ESO President, Else Charlotte Sandset, ESO Secretary General, Martin Dichgans, ESO President Elect, Valeria Caso, ESO Past President. 2023. Available from: https://eso-stroke.or/likelyincrease-in-the-risk-of-death-or-disability-fromstroke-during-the-covid-19-pandemic/
6. Луценко И. Научно-консультативный комитет Инсульты при COVID-19: патогенетические аспекты, клинические проявления и рекомендации ведущих организаций по борьбе с инсультом [Интернет]. АКИpress «Здоровье». 2020. Режим доступа: https://zdorovie.akipress.org/news:1618419/?from=akikg. [Lucenko I. Nauchno-konsul'tativnyj komitet. Insul'ty pri COVID-19: patogeneticheskie aspekty, klinicheskie projavlenija i rekomendacii vedushhih organizacij po bor'be s insul'tom [Internet]. AKIpress «Zdorov'e». 2020. (In Russ.).]
